Showing 81–83 of 83 results
- May of 2018This report brings you up-to-date regarding key TCR-T players, technologies and product candidates, business models, deals and funding opportunities and analyzes the TCR-T pipelines and stakeholders in the field.€ 2150.00
- January of 2018This report informs you about key technologies to identify and validate intracellular targets, to generate TCRs and TCR fusion proteins, to discover TCR-like antibodies, and construct cell-penetrating peptides, proteins and...
€ 2300.00€ 2000.00 - January of 2019This Target Pipeline List provides an overview of agonist antibodies and fusion proteins targeting death receptor 4 and/or 5 in development for treatment of cancer.€ 100.00